HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears


In a retrospective case–control study, we investigated high-risk HPV DNA presence by general primer GP5+/6+ PCR in the last normal cervical smear in the patient archives (i.e. baseline smear) of 57 women who later developed cervical cancer. Also, normal cervical smears of 114 age-matched control women were analysed. High-risk HPV DNA was detected in 37 of the 57 (65%) baseline smears of the case women, and 7 (6%) of 114 smears of the control women (OR 28, 95% Cl 11–72). The HPV positive subsequent smears and cervical cancer biopsies of the case women contained the same HPV type as was detected in the baseline smear. After cytological revision, the baseline smears of 48 case women (84%) were reclassified as abnormal, 33 (69%) of which scored high-risk HPV DNA positive. Ultimately, an undisputable normal baseline smear was found in only 10 case women. In 7 (70%) of them this smear was HPV positive, whereas only 7 (7%) of 104 revised, undisputable normal smears of control women were high-risk HPV positive (OR 32, 95% Cl 6.8–153). The results showed that (1) high-risk HPV presence precedes abnormal cytology in women who develop cervical cancer, and (2) high-risk HPV testing signals false-negative smears of women at risk of cervical cancer. © 2001 Cancer Research Campaign

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication


  1. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796–802

  2. Cuzick J, Terry G, Ho L, Monaghan J, Lopes A, Clarkson P and Duncan I (2000) Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 82: 1348–1352

  3. De Roda Husman A-M, Walboomers JMM, Meijer CJLM, Risse EKJ, Schipper MEI, Helmerhorst THJM, Bleker OP, Delius H, van den Brule AJC and Snijders PJF (1994) Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 56: 802–806

  4. Ho GYF, Bierman R, Beardsley L, Chang CJ and Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423–428

  5. Hopman EH, Rozendaal L, Voorhorst FJ, Walboomers JMM, Kenemans P and Helmerhorst THJM (2000) High risk HPV in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy. BJ Obstet Gynaecol 107: 600–604

  6. IARC (1995) Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses 64, Lyon: International Agency for Research on Cancer

  7. Jacobs MV, Snijders PJF, van den Brule AJC, Helmerhorst THJM, Meijer CJLM and Walboomers JMM (1997) A general primer GP5+/GP6+ mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35: 791–795

  8. Jacobs MV, Zielinski GD, Meijer CJLM, Pol RP, Voorhorst FJ, de Schipper FA, Runsink AP, Snijders PJF and Walboomers JMM (2000) A simplified and reliable HPV testing of archival Papaniculaou-stained archival smears: application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer 82: 1421–1426

  9. Josefsson AM, Magnusson PKE, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Kragh Andersen P, Melbeye M, Adami HO and Gyllensten UB (2000) Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2189–2193

  10. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D and Kiviat NB (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327: 1272–1278

  11. Meijer CJLM, Rozendaal L, Van der Linden JC, Helmerhorst THJM, Voorhorst FJ and Walboomers JMM (1997) Human papillomavirus testing for primary cervical cancer screening. Franco E, Monsonego J (eds). New developments in cervical cancer screening and prevention, Oxford: Blackwell Science 338–347

  12. Melkert PWJ, Hopman E, Van den Brule AJC, Risse EKJ, Van Diest PJV, Bleker OP, Helmerhorst T, Schipper MEI, Meijer CJLM and Walboomers JMM (1993) Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age dependent. Int J Cancer 53: 919–923

  13. Nobbenhuis MAE, Walboomers JMM, Helmerhorst THJM, Rozendaal L, Remmink AJ, Risse EK, Van der Linden JC, Voorhorst FJ, Kenemans P and Meijer CJLM (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354: 20–25

  14. Robertson JH and Woodend B (1993) Negative cytology preceding cervical cancer: causes and prevention. J Clin Pathol 46: 700–702

  15. Rozendaal L, Walboomers JMM, Van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst THJM, van Ballegooijen M and Meijer CJLM (1996) PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 68: 766–769

  16. Vooijs GP (1987) De advisering bij afwijkende bevindingen van cytologisch onderzoek van de cervix uteri. Ned Tijdschr Geneeskd 131: 1662–1663

  17. Walboomers JMM, De Roda Husman A-M, Snijders PJF, Stel HV, Risse EKJ, Helmerhorst THJM, Voorhorst FJ and Meijer CJLM (1995) Human papillomavirus testing in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol 48: 728–732

  18. Walboomers JMM, Jacobs MV, Van Oostveen JW, Van den Brule AJC, Snijders PJF and Meijer CJLM (1997) Detection of genital HPV infections and possible clinical implication. Gross G, Von Krogh G (eds) Human papillomavirus in dermatovenereology, New York: CRC Press, Boca Raton pp. 341–364

  19. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM and Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19

  20. Wallin KL, Wiklund F, Angström T, Bergman F, Stendahl U, Wadell G, HAllmans G and Dillner J (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341: 1633–1638

  21. Ytitalo N, Josefsson A, Melbye M, Sörensen P, Frisch M, Kragh Andersen P, Sparén P, Gustafsson M, Magnusson P, Pontén J, Gyllensten U and Adami H-O (2000a) Prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 60: 6027–6032

  22. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PKE, Kragh Andersen P, Pontén J, Adami HO & Gyllenstenuo Melbye M (2000b) Consistent high viral load of human papilloma virus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2194–2198

Download references

Author information

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Zielinski, G., Snijders, P., Rozendaal, L. et al. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 85, 398–404 (2001). https://doi.org/10.1054/bjoc.2001.1926

Download citation


  • HPV
  • cervical cancer
  • archival smears: case–control study
  • normal cytology
  • false negative cytology

Further reading